Shattuck Labs (STTK)
(Delayed Data from NSDQ)
$0.73 USD
-0.03 (-3.89%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $0.75 +0.02 (2.46%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
STTK 0.73 -0.03(-3.89%)
Will STTK be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for STTK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for STTK
Down -64.19% in 4 Weeks, Here's Why Shattuck Labs (STTK) Looks Ripe for a Turnaround
After Plunging -68.96% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK)
STTK: What are Zacks experts saying now?
Zacks Private Portfolio Services
STTK Discontinues Cancer Program, Plans Workforce Cut, Stock Falls
Other News for STTK
Catalyst Watch: Amazon Prime Day, Delta earnings and stock-by-stock trade deal implications
Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I ...
12 Health Care Stocks Moving In Monday's After-Market Session
Strategic Advancements and Promising Pipeline Developments Propel Shattuck Labs’ Buy Rating
Shattuck Labs Advances SL-325 Program Amid Financial Progress